hand foot mouth - Nursing Case Study

Pathophysiology

• Primary mechanism: Hand, foot, and mouth disease is primarily caused by coxsackievirus A16, an enterovirus that targets epithelial cells in the oral cavity, hands, and feet, leading to vesicular lesions and inflammation. The virus spreads through direct contact with infected bodily fluids, promoting rapid outbreak, especially in communal settings like schools.

• Secondary mechanism: The virus triggers an immune response characterized by the activation of T-cells and cytokine release, which contributes to the systemic symptoms such as fever and malaise. This immune activation can sometimes lead to more severe complications like viral meningitis or encephalitis, particularly in immunocompromised individuals.

• Key complication: In rare cases, the virus can lead to severe neurological complications, emphasizing the need for careful monitoring of symptoms and supportive care to prevent progression.

Patient Profile

Demographics:

4 years old, male, preschool attendee

History:

• Key past medical history: Asthma diagnosed at age 2, recurrent ear infections

• Current medications: Albuterol inhaler as needed, montelukast daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Fever and rash on hands, feet, and mouth

• Key symptoms: Painful sores in mouth, decreased appetite, irritability, mild respiratory distress

• Vital signs: Temperature 101.5°F, heart rate 125 bpm, respiratory rate 30 breaths per minute, blood pressure 90/55 mmHg

Section 1

Change in Patient Status:

During the second day of hospitalization, the 4-year-old male patient with hand, foot, and mouth disease begins to exhibit a change in his clinical status. Although the fever persists, new symptoms emerge, including increased lethargy and irritability. His parents report that he is sleeping more than usual and is difficult to arouse. Upon physical examination, his heart rate has increased to 135 bpm, and his respiratory rate remains elevated at 32 breaths per minute. His oxygen saturation, previously stable, has dropped to 92% on room air, prompting supplemental oxygen administration. Auscultation of his lungs reveals scattered wheezes, suggesting an exacerbation of his underlying asthma condition, likely triggered by the viral infection.

The emergence of neurological symptoms raises concerns about possible viral spread to the central nervous system. An immediate neurological assessment reveals sluggish pupillary reactions and a positive Brudzinski's sign, indicating possible meningeal irritation. Given the risk of complications such as viral meningitis, a lumbar puncture is considered to evaluate cerebrospinal fluid for evidence of viral involvement. The clinical team is now tasked with balancing the management of his respiratory distress while addressing the potential progression to a more severe neurological condition. The combination of his respiratory compromise and neurological signs necessitates close monitoring in a pediatric intensive care setting, where interventions can be adjusted based on his evolving clinical needs.

This change in status prompts the healthcare team to prioritize differential diagnoses that account for both respiratory and neurological symptoms, considering the potential for overlapping pathophysiological mechanisms. The goal is to stabilize his respiratory function while investigating and addressing possible central nervous system involvement, ensuring a comprehensive approach to his care. The next steps will involve coordinating with pediatric neurology and infectious disease specialists to guide further diagnostic and therapeutic strategies.

Section 2

New Diagnostic Results:

Upon further investigation, the clinical team prioritizes a lumbar puncture to assess the cerebrospinal fluid (CSF) for signs of viral meningitis. The procedure is performed with caution, given the patient's increased lethargy and potential for further neurological compromise. Analysis of the CSF reveals a slight increase in protein levels and a pleocytosis with lymphocytic predominance, findings consistent with viral meningitis. Polymerase chain reaction (PCR) testing of the CSF is pending for enterovirus, a common causative agent in hand, foot, and mouth disease-associated meningitis. Concurrently, blood cultures and a respiratory viral panel are initiated to rule out other possible infections that could exacerbate his condition.

In parallel, the healthcare team conducts a comprehensive metabolic panel to evaluate the patient's electrolyte balance and renal function, given his increased respiratory rate and potential dehydration from persistent fever. Results indicate mild hyponatremia, likely secondary to increased insensible losses and potential syndrome of inappropriate antidiuretic hormone secretion (SIADH), a known complication of viral meningitis. This electrolyte imbalance could contribute to his neurological symptoms, necessitating careful fluid management and possible sodium supplementation.

These diagnostic findings guide the clinical team's next steps in management. The focus remains on stabilizing the patient's respiratory status while addressing the neurological aspects of his condition. The initiation of antiviral therapy is considered, although supportive care remains the cornerstone of treatment. Pediatric neurology and infectious disease specialists collaborate to tailor a comprehensive plan that includes continued monitoring in the pediatric intensive care unit, adjustments to fluid management, and reassessment of his neurological status as further diagnostic results become available. This approach ensures a holistic view of his care, integrating findings from multiple disciplines to optimize outcomes in this complex case.

Section 3

New Complications

As the clinical team continues to closely monitor the patient in the pediatric intensive care unit, new complications arise that necessitate prompt clinical reasoning and intervention. Over the past 24 hours, the patient's respiratory status has become a growing concern. He exhibits increased work of breathing, with accessory muscle use and nasal flaring, indicative of respiratory distress. His oxygen saturation has decreased to 92% on room air, prompting the initiation of supplemental oxygen therapy to maintain adequate oxygenation.

Furthermore, the patient's neurological status appears to be deteriorating. He is now more somnolent and difficult to arouse, with a Glasgow Coma Scale (GCS) score dropping from 14 to 12. This change in mental status raises concerns about further intracranial complications, possibly linked to worsening viral meningitis or the development of cerebral edema. The team conducts a repeat neurological examination, noting sluggish pupillary reactions and decreased responsiveness to stimuli.

In light of these developments, the healthcare team decides to perform an urgent cranial CT scan to rule out any significant intracranial pathology, such as increased intracranial pressure or hydrocephalus. The team also re-evaluates the patient's fluid management strategy, considering the risk of exacerbating potential cerebral edema. These new complications require a reevaluation of the treatment plan, focusing on stabilizing the patient's respiratory and neurological status while awaiting additional diagnostic results. This situation underscores the need for dynamic clinical decision-making, integrating ongoing assessments with evolving diagnostic data to guide the next phase of the patient's care.

Section 4

Following the decision to perform an urgent cranial CT scan, the results reveal mild cerebral edema but no acute hydrocephalus or significant intracranial hemorrhage. This finding suggests that the patient's neurological deterioration is likely due to increased intracranial pressure related to the edema, possibly exacerbated by the viral meningitis. In response to these results, the clinical team initiates a mannitol infusion to reduce intracranial pressure and closely monitors the patient's fluid balance to prevent further complications.

Concurrently, the patient's respiratory status is reassessed. His respiratory rate has increased to 35 breaths per minute, with persistent nasal flaring and retractions, despite supplemental oxygen therapy. Arterial blood gas analysis shows a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 68 mmHg on 3 liters of oxygen via nasal cannula, indicating respiratory acidosis and hypoxemia. The team decides to escalate respiratory support, transitioning to high-flow nasal cannula therapy to enhance oxygen delivery and reduce the work of breathing.

As the interventions are implemented, the healthcare team remains vigilant, conducting continuous assessments to gauge the efficacy of the treatment plan. The combination of neurological and respiratory challenges underscores the complexity of this case, requiring a coordinated, multidisciplinary approach to stabilize the patient while minimizing the risk of further complications. The evolving clinical picture necessitates ongoing critical thinking and timely adjustments to the treatment strategy, setting the stage for the next phase of the patient's care journey.

Section 5

As the high-flow nasal cannula therapy is initiated, the healthcare team observes the patient's response closely. Over the next few hours, there is a noticeable improvement in the patient's oxygenation, with the PaO2 increasing to 78 mmHg and a slight reduction in the respiratory rate to 28 breaths per minute. However, the patient remains tachypneic, and retractions persist, indicating ongoing respiratory distress. The nursing team conducts meticulous neurological assessments, noting that the patient remains lethargic but arousable, a slight improvement from earlier evaluations. Pupillary responses are sluggish but equal, and cranial nerve assessment reveals no new deficits. These findings suggest a partial response to the mannitol infusion, with intracranial pressure likely reduced.

Later in the afternoon, the patient exhibits a new onset of generalized weakness and decreased urine output. Vital signs reveal a blood pressure of 92/58 mmHg, heart rate of 130 beats per minute, and temperature of 38.2°C (100.8°F). Laboratory results show a serum sodium level of 128 mEq/L, indicating hyponatremia, likely secondary to the osmotic diuresis caused by mannitol. The team deliberates on this new complication, considering the balance between managing cerebral edema and preventing electrolyte imbalances. Fluid management becomes a priority, with careful adjustment of intravenous fluids to address hypovolemia while avoiding exacerbation of cerebral edema.

With the patient's condition still precarious, the multidisciplinary team convenes to reassess the overall treatment strategy. The focus shifts to optimizing fluid and electrolyte balance, enhancing supportive care, and preparing for potential further interventions. A nephrology consult is requested to aid in managing the patient's fluid status and electrolyte imbalances, while neurology and pulmonology teams continue to monitor neurological and respiratory parameters, respectively. This evolving scenario underscores the importance of continuous clinical reasoning and careful coordination to navigate the complex interplay of symptoms and treatment effects.